Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Think I just missed the low share price, will probably climb from here on in for a while, although I could be wrong!!
Pfizer consumer health business acquisition talks terminated. Market is reacting well to the news.
I also think that another big reason is that bonds are now more attractive and ii are rebalancing their portfolios. Yield on RB is lower than those bonds and risk at RB is higher for reasons explained. Hard to see value right now, but wait 3-6months and it might turnaround (provided 1-2 positive qtrly, market expectations-beating results)
I agree. Personal target of mine is not too far off: £47
Those who have followed Reckitt Benckiser is wondering why the shares have fallen so much, despite the combined business being much larger. One of the main reason is the increase in debt. The one distinction is before the acquisition net interest cover was over 100 times (2016: net interest cost was �16m), compared to today�s 10 times cover (2017: net interest cost came to �223m). And big financial institutions are doubting if the �400m in post-tax profit from Mead Johnson would compensate for the lost post-tax profit from their Food Division which equated to �100m and the �200m incremental increase in net interest costs. As I assess the whole business and the technical analysis, I feel RB will experience further short-term share price decline in the next six months and should target �52 per share. For more reasons, why investors are abandoning RB in the short-term and why the share price will target �52 or lower, click here for more http://bit.ly/2oHkK2X
if you look at the 12 month broker forecast 6-9 months ago, you saw targets such 8,000p-10,000. Since the last financial update it has been more 5,000-7,200. So we are def in a "cooling off"-period
mid to long term, probably yes. Though the Mead Johnson acquisition will need to succeed. This is a totally new area for the business, with skill sets they do not have at the core of the company so it remains to be seen. Not all their acquisitions have been a success; so fingers crossed. I don’t think the sp will turnaround until the overhang of the Pfizer M&A has cleared and until we see 1-2 market beating quarters. On that basis I am waiting until mid year to get back in. I may be wrong to wait, but need some confirmation on the above for me to be totally convinced. Good luck to all holders in the mean time
This stock is most definitely a conviction buy. The Company is of larger than GSK in terms of revenues and equity. This stock will be going up soon, no doubt here.
Looks like a buy to me but WTF do I know!!? Not betting against the market.
clearly the short term risks materialised, driven by both ket factors. On the Pfizer M&A, I read that analysts expect a equity raise to (part)fund the deal, which is further putting negative pressure on the sp. I suspect further erosion of the SP given the 2 risk factors will be around for some time, at the very least until Q1/18 results and even that may not be sufficient if we haven't seen any white smoke by then on the M&A-front. Def a share to watch....and hopefully buy at some point, but now seem way too soon IMO
Sold out over the summer at �80.00.....now getting to this point where I think it may be interesting to get back into this share. Short term risks I see are: 1. Full year 2017 financials, and specifically Q4: we have had several poor qrts here and another one IMHO could create a further nose dive during Q 2018, before starting to recover subject to positive new following the integration of Mead Johnson. Positive being NR growth (not cost cutting. Any idiot can cut costs) 2. Potential Pfizer acquisition: would further massively bump up debt and put huge operational strains on the organisation. Whilst convinced great for the longer term, it will not be good for the SP in 2018. Unless the raise capital via the House Hold business. Either by selling it off or by floating it onto the market under a separate name. Thoughts?
Reason why this SP has dropped is because RB has posted poor sales performances in the last couple of Qrtly results. It's that simple. Same thing happened today: LFL growth is down and lower vs city's expectations. That is a massive thing for a company that used to beat expectations from the city at each quarterly update for over a decade. In addition the virus attack disrupted supply to the trade, law suit in Korea and board member leaving the company. Short term, I don't expect a turnaround but mid term this could be an exciting share. The company always does what is right for the business and the restructure announced today is further testimony to that. Def a share to watch for me and look for an interesting entry point which may be between here and mid 60's - all IMHO
Did this go up today ??? Hawkey
four board members left/leaving
As a casual glancer at many bbs, I am concerned that no one has yet commented on the sp price drop from £80 to £67. I can't offer an explanation. Is there anyone who can. The speculation in the press about RB being a target is more worrying given the low sp and it's vulnerability to a TO - I imagine such press will either hike the s/ price by the speculators or increase the chance of US multinational (Kraft/Heinz) having a go. What do others think?
it's a brilliant move: massive business with high accretive margins to company average excellent stuff plus now selling low margin, slow growth food business great moves!
Expected much comment on Mead takeover and market reaction here but nowt since last August!
Change can be double-edged. We need to be careful what we wish for. Change can also be a harbinger of pain
Church & Dwight Co., the maker of Trojan condoms and Arm & Hammer baking soda, rose the most in more than eight years on reports that it might be a takeover target. The shares soared as much as 11 percent to $107.36 in New York on Thursday -- the biggest intraday gain since November 2007 -- amid reports in Negocios.com that bidders including Reckitt Benckiser Group Plc and Procter & Gamble Co. are circling Church & Dwight. Reckitt Benckiser plans to offer $23 billion next week to buy the company, Negocios.com said Thursday, citing people it didn’t identify. This will cause a 10% drop for RB.!
desperately trying to shore up RB. set for big correction IMO possibly low as 6500!
Apologies for board hopping but- The petition is going quite well; ~5100 signatures so far. Although it really needs a turbo boost. https://petition.parliament.uk/petitions/112044/sponsors/frRbCOsOLO6QqIN82UOX This petition was stalled in parliament since 12th Aug 15; finally green lit on 12th feb 2016. The FCA don't even reply on the matter, now is your chance to have your say. If you hate seeing buys reported as sells etc!!!!!! Has already been sent to Martin Lewis, Daily Mail, Moneyweek & Watchdog. My local MP supported this petition by writing to the petitions committee to help un-stall it. There’s 650 MP’s in Westminster, So have you written to your MP? 649 to go! If this petition doesn’t reach 10,000; then imo we might as well have not bothered as it will almost certainly be filed B1N; @ 10,000 the government should respond. We are currently getting approx. 100 new signatures a week, but need 3x that amount to reach the target with only 15 weeks to go. So – If you haven’t yet signed or indeed have but haven’t passed it on to others, then now’s the time to do so. If each person who has signed can get just one other person to sign then we will double the total immediately. I have posted to all aim listed gas n oilies, currently doing the footsy 100. But I can only do so much to push this. Really need you guys & gals to help. Thanks to all who have signed so far.
getting very concerned over the situation in South Korea, following on from the Australian fine, I think there could be some fall out in our far easten operations.
SP has a good chance of dropping a little tomorrow, I think. Time to buy. The shareholder revolt over salaries etc. is less critical than the length of time some of the directors have served and the need for fresh blood.
i think tomorrow you will be eating those words.....
Strong buy for any portfolio - this share never lets you down!